PAPER Zhang HL, Hu S, Yang P, Long HC, Ma QH, Yin DM, Xu GY
SEARCH RESULTS
329654 RESULTS
PAPER Li Z, Liu J
Thyroid dysfunction and Alzheimer's disease, a vicious circle.
Front Endocrinol (Lausanne). 2024;15:1354372. Epub 2024 Feb 14 PubMed: 38419953PAPER Parker EJ, Orchard SG, Gilbert TJ, Phung JJ, Owen AJ, Lockett T, Nelson MR, Reid CM, Tonkin AM, Abhayaratna WP, Gibbs P, McNeil JJ, Woods RL
The ASPREE Healthy Ageing Biobank: Methodology and participant characteristics.
PLoS One. 2024;19(2):e0294743. Epub 2024 Feb 29 PubMed: 38421995PAPER Newton C, Pope M, Rua C, Henson R, Ji Z, Burgess N, Rodgers CT, Stangl M, Dounavi ME, Castegnaro A, Koychev I, Malhotra P, Wolbers T, Ritchie K, Ritchie CW, O'Brien J, Su L, Chan D, PREVENT Dementia Research Programme
Entorhinal-based path integration selectively predicts midlife risk of Alzheimer's disease.
Alzheimers Dement. 2024 Feb 29; PubMed: 38421123PAPER Mughal A, Sackheim AM, Koide M, Bonson G, Ebner G, Hennig G, Lockette W, Nelson MT, Freeman K
Pathogenic soluble tau peptide disrupts endothelial calcium signaling and vasodilation in the brain microvasculature.
J Cereb Blood Flow Metab. 2024 Feb 29;:271678X241235790. PubMed: 38420777PAPER Zalon AJ, Quiriconi DJ, Pitcairn C, Mazzulli JR
α-Synuclein: Multiple pathogenic roles in trafficking and proteostasis pathways in Parkinson's disease.
Neuroscientist. 2024 Feb 29;:10738584241232963. PubMed: 38420922PAPER Dos Passos PM, Hemamali EH, Mamede LD, Hayes LR, Ayala YM
RNA-mediated ribonucleoprotein assembly controls TDP-43 nuclear retention.
PLoS Biol. 2024 Feb;22(2):e3002527. Epub 2024 Feb 29 PubMed: 38422113PAPER Gul Q, Karim N, Shoaib M, Zahoor M, Rahman MU, Bilal H, Ullah R, Alotaibi A
Vanillin derivatives as antiamnesic agents in scopolamine-induced memory impairment in mice.
Heliyon. 2024 Feb 29;10(4):e26657. Epub 2024 Feb 19 PubMed: 38420420PAPER Tazaki M
A review: effects of neurofeedback on patients with mild cognitive impairment (MCI), and Alzheimer's disease (AD).
Front Hum Neurosci. 2023;17:1331436. Epub 2024 Feb 14 PubMed: 38420112PAPER Zhou C, Yang C, Ai Y, Fang X, Zhang A, Wang Y, Hu H
Valid olfactory impairment tests can help identify mild cognitive impairment: an updated meta-analysis.
Front Aging Neurosci. 2024;16:1349196. Epub 2024 Feb 13 PubMed: 38419646PAPER Dong X, Tsang CC, Wan JY, Chisholm-Burns MA, Finch CK, Tsao JW, Browning JA, Garuccio J, Zeng R, Wang J
Effects of Medicare Part D medication therapy management on racial/ethnic disparities in adherence to antidementia medications among patients with Alzheimer's disease and related dementias: An observational study.
Explor Res Clin Soc Pharm. 2024 Mar;13:100420. Epub 2024 Feb 10 PubMed: 38420610PAPER Josephs KA, Josephs KA Jr
Prosopagnosia: face blindness and its association with neurological disorders.
Brain Commun. 2024;6(1):fcae002. Epub 2024 Jan 5 PubMed: 38419734PAPER Wolff AW, Bidner H, Remane Y, Zimmer J, Aarsland D, Rascol O, Wyse RK, Hapfelmeier A, Lingor P
Protocol for a randomized, placebo-controlled, double-blind phase IIa study of the safety, tolerability, and symptomatic efficacy of the ROCK-inhibitor Fasudil in patients with Parkinson's disease (ROCK-PD).
Front Aging Neurosci. 2024;16:1308577. Epub 2024 Feb 14 PubMed: 38419648PAPER Xu M, Liu J, Liu Q, Gong Y, Li Y, Zhang J, Shi S, Shi Y
Preliminary study on early diagnosis of Alzheimer's disease in APP/PS1 transgenic mice using multimodal magnetic resonance imaging.
Front Aging Neurosci. 2024;16:1326394. Epub 2024 Feb 14 PubMed: 38419647PAPER Alava B, Hery G, Sidhom S, Gutierrez-Monreal M, Prokop S, Esser KA, Abisambra J
Targeted brain-specific tauopathy compromises peripheral skeletal muscle integrity and function.
Aging Brain. 2024;5:100110. Epub 2024 Feb 24 PubMed: 38419621Current Filters
- Date Range : All x